ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ALL Atlantic Lithium Limited

19.90
-0.55 (-2.69%)
24 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Atlantic Lithium Limited LSE:ALL London Ordinary Share AU0000237554 ORD NPV (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.55 -2.69% 19.90 19.92 20.20 20.50 19.96 20.50 624,170 16:35:11
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Iron Ores 0 -12.19M -0.0200 -9.98 121.6M
Atlantic Lithium Limited is listed in the Iron Ores sector of the London Stock Exchange with ticker ALL. The last closing price for Atlantic Lithium was 20.45p. Over the last year, Atlantic Lithium shares have traded in a share price range of 16.48p to 36.00p.

Atlantic Lithium currently has 609,241,660 shares in issue. The market capitalisation of Atlantic Lithium is £121.60 million. Atlantic Lithium has a price to earnings ratio (PE ratio) of -9.98.

Atlantic Lithium Share Discussion Threads

Showing 201 to 220 of 4275 messages
Chat Pages: Latest  15  14  13  12  11  10  9  8  7  6  5  4  Older
DateSubjectAuthorDiscuss
31/7/2012
08:06
Brilliant set of results this morning for Allocate software - smashing expectations.

Dividends start flowing and fascinating new acquisition of patient flow management system.

Is this the most undervalued company in the FTSE?

king_roster_iii
24/2/2012
12:33
Interesting ALLOCATE SOFTWARE was 74p when this was published:
now it's 87p..still more upside according to brokers. company makes more money when economy in trouble..jobless 3mln..oh boy are we in trouble.

ipoman2
07/2/2012
10:52
Staff rostering specialist Allocate Software (LON:ALL) said today underlying revenues grew in its latest half-year as momentum continued to build in its core NHS market.
Revenues overall rose to £16 million from £15.9 million in the half year to November, with underlying sales up by 15% excluding acquisitions and a £3 million contract in Australia in the previous year.

lucky_punter
09/1/2012
13:07
Allocate Software - Healthy start
Click for report
1:05 PM

texas tea
25/11/2011
09:42
Ageing populations, growing demand for treatment and cuts to healthcare budgets are problems that face hospitals all across the developed world.
The pressure is providing an opportunity for IT companies specialising in the health arena such as staff rostering specialist Allocate Software (LON:ALL).

lucky_punter
11/11/2011
07:39
From todays SEC announcement

The key positive
contributors to performance in the period were Allocate, Vintage and Pinewood,
which rose 4%, 11% and 2% respectively. Allocate released final results ahead
of expectations and forecasts were upgraded. Although this has been a
successful investment so far for the SEC, we believe that the considerable
progress made over the past two years has failed to be fully reflected in its
share price. Since May, we have increased our holding by about 45%. Vintage's
movement was a result of the strong performance in its highly diversified
private equity portfolios.

the shuffle man
06/9/2011
12:50
Looks like a good set of final figures with an encouraging statement. Be interested to see the semi official "analysts forecasts" for the current year.

Only grouse I ever have, although it applies to almost every acquisitive company, is when advisers consider it almost mandatory to include in the official acquisitive documents the statement that "in terms of eps the acquisition will be enhancing in the first year". However then there seems to be a drag on earnings in the second year!It's just a general grouse.

Pity about the share price but it is a bear market however short-or long!

gregmorg
15/7/2011
10:56
Interview with Ian Bowles -
rockafella2
31/3/2011
09:15
Thanks n1blet. There was a fortnightly magazine called Techmark years ago(when I was alive!) and it was very authoritative. The one you refer to is from a new organisation according to its site and which appears to aim to be precisely that. Not quite what I expected when you referred to analysts which I had assumed referred to "sell side". Still all comment spreads the word and the more write ups the better!.
gregmorg
30/3/2011
02:16
gregmorg they are, followers of the whole IT world:-

Techmarketview

n1blet
23/3/2011
10:44
n1blet.
Purely for my added information what analyst comment are you referring to?Numis is the shop whilst Edison is a paid research house. If there are others researching the stock as well then that would be excellent in terms of spreading the word as this tiddler grows.I await your reponse.

gregmorg
22/3/2011
23:49
analyst comment, that they are def producing what the NHS needs, to achieve cost saving, but with the abolition of PHT's & setting up of GP consortia's, there is some hiatus amongst the signers off of contracts, whilst contract growth is running despite all this at 30%pa.

+ overall inotherwards, Not read rec above yet, but looks to still be very low profile as a business.

n1blet
22/3/2011
10:59
Yesterday's 3rd qtr update was fine other than reading between the lines there seemed a touch of caution re timing of contracts being signed off. Whether that is the forerunner of something else is at this stage unknown but it obviously has caused a little concern. It seems that recent momentum has slowed but given the background that is hardly surprising.Still, fingers crossed for the longer term!
gregmorg
01/3/2011
16:51
GCI recommendation by analyst Ben Jaglom
akhtar8
23/2/2011
09:50
Yes a nice thing to see. A new non exec buying a decent chunk of shares is quite a rare thing these days. For very obvious reasons I hope he makes a very large profit! This so makes a change to the usual PLC director stance these days of claiming to be on the side of shareholders yet all they have done is to benefit from very generous executive option schemes whilst also being over paid. Nice to see someone "putting his money etc".
gregmorg
23/2/2011
08:28
A decent initial purchase of 50,000 shares by Richard King...
ZZZ

zorija
13/2/2011
11:31
Thanks Aim_Trader a very informative video that I've now added to the header.
jakleeds
13/2/2011
10:52
Ian Bowles of Allocate Software says he's confident Allocate will continue to grow turnover

Friday, February 11, 2011

Ian Bowles, Chief Executive of Allocate Software, tells Proactive Investors that he confident that Allocate can sustain growth over the next 2-3 years. Ian says though that the difficulty encountered by Dynamic Change (healthcare sector), with the Primary Care Trusts being dismantled, can be overcome for two reaso

aim_trader
11/2/2011
09:28
thanks greg I stand corrected!
littleweed
10/2/2011
10:54
Not that it matters but I don't actually think this is an all time high for the share price!

That may surprise most investors but it was floated on the full market as MSW(before changing its name to Manpower etc) in the mid 1990's. The price then that I recall was something like 97p. However it was a painful experience and a real disaster. Fortunately it was recued and more than once but it survived. One executive and one non exec survive from that horrible period. Anyway it's a completely different animal now and one that has become quite pleasing with maybe even more pleasure to come. Purely a trip down memory lane!

gregmorg
Chat Pages: Latest  15  14  13  12  11  10  9  8  7  6  5  4  Older

Your Recent History

Delayed Upgrade Clock